Skip to main content
SURAKSHA DIAGNOSTIC LIMITED logo

SURAKSHA DIAGNOSTIC LIMITED — Investor Relations & Filings

Ticker · SURAKSHA ISIN · INE877V01027 LEI · 335800SJSOH7ZQHTPO56 BSE.NS Human health and social work activities
Open in API
Filings indexed 144 across all filing types
Latest filing 2025-01-16 Board/Management Inform…
Country IN India
Listing BSE.NS SURAKSHA

About SURAKSHA DIAGNOSTIC LIMITED

https://www.surakshanet.com

Suraksha Diagnostic Limited is a prominent diagnostic healthcare service provider primarily operating in Eastern India. The company offers a comprehensive range of pathology and radiology services, including clinical laboratory tests, molecular diagnostics, and advanced imaging such as MRI, CT scans, ultrasound, and X-rays. It operates a network of diagnostic centers and polyclinics, providing integrated healthcare solutions that encompass specialized consultations and preventive health check-ups. The organization is recognized for its commitment to quality, maintaining international standards through NABL and CAP accreditations. By leveraging advanced medical technology and a robust logistics framework for home collection, the company serves a diverse patient base, focusing on accurate clinical outcomes and accessible diagnostic care.

Recent filings

Filing Released Lang Actions
Resignation
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the resignation of the Chief Financial Officer (CFO), Mr. Amit Saraf. It references compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including changes in key managerial personnel. The document includes details about the resignation, the last working day, and an annexure with required information under SEBI regulations. There is no financial data, earnings information, or report attached or referenced as being published. The document is clearly an announcement of a management change, specifically the resignation of a senior executive. Therefore, it fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2025-01-16 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing them about the change in the Corporate Identification Number (CIN) and the listing status of Suraksha Diagnostic Limited. It includes details about the updated CIN and confirms the company's listing status change from 'No' to 'Yes'. The letter also attaches a copy of the company's Master Data from the Ministry of Corporate Affairs (MCA) website for reference. The document is short (3460 characters) and primarily serves as an official notification of corporate data changes rather than a financial report or detailed filing. There are no financial statements, audit information, or detailed management discussion. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like Annual Report, Interim Report, or Capital Update.
2025-01-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositaries and Participants) Regulations, 2018, confirming dematerialization of securities for the quarter ended 31 December 2024. It is addressed to stock exchanges and signed by the company secretary and the registrar and share transfer agent. The document is short (3171 characters) and primarily serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is a regulatory compliance certificate related to securities dematerialization, which fits best under Regulatory Filings (RNS) as a miscellaneous regulatory announcement that does not fit other categories.
2025-01-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 07 January 2025 addressed to stock exchanges regarding the schedule of an analyst/institutional investor meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an intimation about a meeting schedule, not a financial report or detailed presentation. The document length is only 2234 characters, which is short and does not contain financial data or detailed analysis. It is an announcement of an event (investor meeting) rather than the meeting transcript or presentation itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-07 English
Copy of Newspaper Publication
Legal Proceedings Report Classification · 95% confidence The document is a detailed notice regarding the sale of immovable properties under the Securitisation and Reconstruction of Financial Assets and Enforcement of Security Interest Act, 2002 (SARFAESI Act). It includes possession notices, demand notices, and e-auction sale notices issued by financial institutions (Grihum Housing Finance Limited, DCB Bank Limited, Yes Bank Limited) for recovery of dues from borrowers. The content is regulatory in nature, related to enforcement of security interests and auction sales of secured assets due to loan defaults. It does not contain financial statements, management discussion, earnings data, or any corporate governance or board management information. It is not an announcement of a report but a legal and regulatory notice under SARFAESI. Therefore, the most appropriate classification is Legal Proceedings Report (LTR).
2025-01-07 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice regarding a Postal Ballot for shareholders of Suraksha Diagnostic Limited. It includes information about the e-voting process, cut-off dates, appointment of a scrutinizer, and the special resolution to ratify the Employee Stock Option Scheme 2024. The document references compliance with SEBI regulations and the Companies Act, 2013. It is not a report of voting results but the notice calling for the vote. It is not a financial report, earnings release, or management discussion. The document is a formal communication to shareholders to solicit votes on a resolution via postal ballot and remote e-voting. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2025-01-06 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.